Ahmadi M, Morshedzadeh F, Ghaderian S, Mousavi P, Habibipour L, Peymani M, Abbaszadegan M, Ghafouri-Fard S (2023) Carcinogenic roles of MAFG-AS1 in human cancers. Clin Transl Oncol 26(1):52–68. https://doi.org/10.1007/s12094-023-03246-x
Article PubMed CAS Google Scholar
Atas N, Varan O, Babaoglu H, Satis H, Bilici Salman R, Celik B, Tufan A, Haznedaroglu S, Goker B, Ozturk M (2019) Work productivity in patients with Behçet disease and its association with disease activity and quality of life. Br J Occup Ther 82(6):376–382. https://doi.org/10.1177/0308022619834184
Aydındoğan S, Velioğlu E, Hakkı S (2023) Behçet’s disease and periodontal disease. Curr Oral Health Rep 10(2):52–58. https://doi.org/10.1007/s40496-023-00332-5
Bettiol A, Alibaz-Oner F, Direskeneli H, Hatemi G, Saadoun D, Seyahi E, Prisco D, Emmi G (2023) Vascular Behçet syndrome: From pathogenesis to treatment. Nat Rev Rheumatol 19(2):111–126. https://doi.org/10.1038/s41584-022-00880-7
Article PubMed CAS Google Scholar
Cui S, Yang X, Zhang L, Zhao Y, Yan W (2018) LncRNA MAFG-AS1 promotes the progression of colorectal cancer by sponging miR-147b and activation of NDUFA4. Biochem Biophys Res Commun 506(1):251–258. https://doi.org/10.1016/j.bbrc.2018.10.112
Article PubMed CAS Google Scholar
Dabbaghi K, Mashatan N, Faraz O, Bashkandi A, Shomoossi N, Tabnak P (2023) A review on the roles and molecular mechanisms of MAFG-AS1 in oncogenesis. Pathol Res Pract 154348. https://doi.org/10.1016/j.prp.2023.154348
Davatchi F, Assaad-Khalil S, Calamia K, Crook J, Sadeghi-Abdollahi B, Schirmer M, Tzellos T, Zouboulis C, Akhlagi M, Al-Dalaan A, Alekberova Z, Ali A, Altenburg A, Arromdee E, Baltaci M, Bastos M, Benamour S, Ben Ghorbel I, Boyvat A, Ziaei N (2014) The International Criteria for Behçet’s Disease (ICBD): A collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol 28(3):338–347. https://doi.org/10.1111/jdv.12107
Dong Y, Feng S, Dong F (2020) Maternally-expressed gene 3 (MEG3)/miR-143-3p regulates injury to periodontal ligament cells by mediating the AKT/inhibitory κB kinase (IKK) pathway. Med Sci Monit. https://doi.org/10.12659/MSM.922486
Article PubMed PubMed Central Google Scholar
Elsherbeny M, Elsergany A, Shaker O (2023) Association of lncRNA MEG3 Rs7158663 polymorphism and serum expression with colorectal cancer in Egyptian patients. Rep Biochem Mol Biol 12(1):102–111. https://doi.org/10.52547/rbmb.12.1.102
Gao Z, Zheng G, Gong X, Hu H, Shao L, Pang Y, Wang Y, Qi A (2022) LncRNA MAFG-AS1 deregulated in breast cancer affects autophagy and progression of breast cancer by interacting with miR-3612 and FKBP4 in vitro. Biochem Biophys Res Commun 616:95–103. https://doi.org/10.1016/j.bbrc.2022.05.020
Article PubMed CAS Google Scholar
Greco A, De Virgilio A, Ralli M, Ciofalo A, Mancini P, Attanasio G, de Vincentiis M, Lambiase A (2018) Behçet’s disease: New insights into pathophysiology, clinical features and treatment options. Autoimmun Rev 17(6):567–575. https://doi.org/10.1016/j.autrev.2017.12.006
Article PubMed CAS Google Scholar
Gu F, Huang X, Huang W, Zhao M, Zheng H, Wang Y, Chen R (2023) The role of miRNAs in Behçet’s disease. Front Immunol. https://doi.org/10.3389/fimmu.2023.1249826
Article PubMed PubMed Central Google Scholar
Huang X, Zhang W, Pu F, Zhang Z (2023a) LncRNA MEG3 promotes chemosensitivity of osteosarcoma by regulating antitumor immunity via miR-21-5p/p53 pathway and autophagy. Genes & Diseases 10(2):531–541. https://doi.org/10.1016/j.gendis.2021.11.004
Huang Z, Zhang M, Li J, Lou C (2023b) Long non-coding RNA MAFG-AS1: A promising therapeutic target for human cancers. Biomed Pharmacother 163. https://doi.org/10.1016/j.biopha.2023.114756
Article PubMed CAS Google Scholar
Konstantinidis A, Pardali D, Adamama-Moraitou K, Gazouli M, Dovas C, Legaki E, Brellou G, Savvas I, Jergens A, Rallis T, Allenspach K (2020) Colonic mucosal and serum expression of microRNAs in canine large intestinal inflammatory bowel disease. BMC Vet Res 16(1):69. https://doi.org/10.1186/s12917-020-02287-6
Article PubMed CAS Google Scholar
Lawton G (2004) The Behcet’s disease activity index. Rheumatology 43(1):73–78. https://doi.org/10.1093/rheumatology/keg453
Article PubMed CAS Google Scholar
Li Z, Yang L, Liu X, Wang X, Pan Y, Luo J (2018) The long noncoding RNA MEG3 and its target miR-147 regulate JAK/STAT pathway in advanced chronic myeloid leukemia. EBioMedicine 34:61–75. https://doi.org/10.1016/j.ebiom.2018.07.013
Article PubMed PubMed Central Google Scholar
Li P, Shi Y, Guo M, Xu H, Zhan M, Wang Z, Chen Y (2022) MAFG-AS1 is a prognostic biomarker and facilitates prostate cancer progression. Front Oncol. https://doi.org/10.3389/fonc.2022.856580
Article PubMed PubMed Central Google Scholar
Li K, Gong Q, Xiang X, Guo G, Liu J, Zhao L, Li J, Chen N, Li H, Zhang L, Zhou C, Wang Z, Zhuang L (2023) HNRNPA2B1-mediated m6A modification of lncRNA MEG3 facilitates tumorigenesis and metastasis of non-small cell lung cancer by regulating miR-21-5p/PTEN axis. J Transl Med 21(1):382. https://doi.org/10.1186/s12967-023-04190-8
Article PubMed PubMed Central CAS Google Scholar
Limthongkul J, Mapratiep N, Apichirapokey S, Suksatu A, Midoeng P, Ubol S (2019) Insect anionic septapeptides suppress DENV replication by activating antiviral cytokines and miRNAs in primary human monocytes. Antiviral Res 168:1–8. https://doi.org/10.1016/j.antiviral.2019.04.012
Article PubMed CAS Google Scholar
Lin L, Hu K (2021) MiR-147: Functions and implications in inflammation and diseases. MicroRNA 10(2):91–96. https://doi.org/10.2174/2211536610666210707113605
Article PubMed PubMed Central CAS Google Scholar
Liu G, Friggeri A, Yang Y, Park Y, Tsuruta Y, Abraham E (2009) miR-147, a microRNA that is induced upon Toll-like receptor stimulation, regulates murine macrophage inflammatory responses. Proc Natl Acad Sci 106(37):15819–15824. https://doi.org/10.1073/pnas.0901216106
Article PubMed PubMed Central Google Scholar
Liu C, Liang T, Zhang Z, Chen J, Xue J, Zhan X, Ren L (2023) MEG3 alleviates ankylosing spondylitis by suppressing osteogenic differentiation of mesenchymal stem cells through regulating microRNA-125a-5p-mediated TNFAIP3. Apoptosis 28(3–4):498–513. https://doi.org/10.1007/s10495-022-01804-2
Article PubMed CAS Google Scholar
Lu Y, Qie D, Yang F, Wu J (2023) LncRNA MEG3 aggravates adipocyte inflammation and insulin resistance by targeting IGF2BP2 to activate TLR4/NF-κB signaling pathway. Int Immunopharmacol 121. https://doi.org/10.1016/j.intimp.2023.110467
Article PubMed CAS Google Scholar
Marinello D, Palla I, Lorenzoni V, Andreozzi G, Pirri S, Ticciati S, Cannizzo S, Del Bianco A, Ferretti E, Santoni S, Turchetti G, Mosca M, Talarico R (2023) Exploring disease perception in Behçet’s syndrome: combining a quantitative and a qualitative study based on a narrative medicine approach. Orphanet J Rare Dis 18(1):58. https://doi.org/10.1186/s13023-023-02668-8
Article PubMed PubMed Central CAS Google Scholar
Mehana N, Ghaiad H, Hassan M, Elsabagh Y, Labib S, Abd-Elmawla M (2022) LncRNA MEG3 regulates the interplay between Th17 and Treg cells in Behçet’s disease and systemic lupus erythematosus. Life Sci 309. https://doi.org/10.1016/j.lfs.2022.120965
Article PubMed CAS Google Scholar
Pan X, He L (2020) LncRNA MEG3 expression in sepsis and its effect on LPS-induced macrophage function. Cell Mol Biol 66(5):131–136. https://doi.org/10.14715/cmb/2020.66.5.23
Perazzio SF, Allenspach EJ, Eklund KK, Varjosalo M, Shinohara MM, Torgerson TR, Seppänen MRJ (2020) Behçet disease (BD) and BD‐like clinical phenotypes: NF‐κB pathway in mucosal ulcerating diseases. Scand J Immunol 92(5). https://doi.org/10.1111/sji.12973
Posarelli C, Maglionico M, Talarico R, Covello G, Figus M (2020) Behçet’s syndrome and ocular involvement: Changes over time. Clin Exp Rheumatol 38 Suppl 127(5):86–93
留言 (0)